ArticleCell death and differentiation2025

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Jia-Nan Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.